These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15272497)
1. Targeted lung cancer therapies. Farmer G Nat Rev Drug Discov; 2004 Jul; 3(7):547-8. PubMed ID: 15272497 [No Abstract] [Full Text] [Related]
2. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor. Crawford J J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor as a target in cancer therapy. Kim ES J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S87-95. PubMed ID: 19795581 [TBL] [Abstract][Full Text] [Related]
10. Targeted therapies in lung cancer: a tribute to advancements in clinical research. McGee L ONS Connect; 2007; 22(8 Suppl):27-8. PubMed ID: 17824552 [No Abstract] [Full Text] [Related]
11. Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer. Agelaki S; Georgoulias V Expert Opin Emerg Drugs; 2005 Nov; 10(4):855-74. PubMed ID: 16262567 [TBL] [Abstract][Full Text] [Related]
12. What phase III trials are needed to improve the treatment of advanced non-small-cell lung cancer? Saijo N Nat Clin Pract Oncol; 2005 Jun; 2(6):275. PubMed ID: 16264964 [No Abstract] [Full Text] [Related]